|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||35.77 - 36.12|
|52-week range||29.83 - 36.21|
|PE ratio (TTM)||26.31|
|Earnings date||31 Oct 2017|
|Dividend & yield||1.28 (3.61%)|
|1y target est||37.85|
The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
The Graham Cassidy bill appears dead, but the stock market has found new life.
One biopharma's loss is another biopharma's gain when it comes to rare disease drug trials.